Benefical effects of V2-vasopressin antagonist (ANTAG) in the hyponatremia of clinical cardiac failure (CHF), SIADH and liver cirrhosis (CI) (Abstract). - Kuhn,K.; Reimann,D.; Gross,P. (Kidney & Blood Pressure Research, 1998)